Sustainalytics dual-scoring Controversy research highlights how current market leaders Novo and Lilly are involved in a combined multi-district litigation over their GLP-1 drugs alleged link to gastrointestinal injuries, underscoring ongoing legal risks and associated impact safety risks
Ranjan Das, Rush University Medical Center, United States
Owner's reply Always trying my level best service Customer Reviews Rated 0 out of 5 0 reviews Rated 5 out of 5 0 Rated 4 out of 5 0 Rated 3 out of 5 0 Rated 2 out of 5 0 Rated 1 out of 5 0 Reviews Clear filters There are no reviews yet
Xu X, Zhang Y, Meng C, Zheng W, Wang L, Zhao C, et al
As of May 2026, generic semaglutide retails locally in Canada for roughly $88 to $100 CAD per month at major pharmacies, according to CBC News reporting
Ask us a question: Disclaimer: Ozempic, Mounjaro and Zepbound are indicated for the treatment of type 2 diabetes but may be considered for off-label use in weight loss when suitable
